Viatris Technical Analysis



As of date:4/22/2024
VTRS stock price:11.25
VTRS 50 DMA:12.02
VTRS 200 DMA:10.57
VTRS MACD (200-50):-1.45
VTRS RSI:24.82
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)24.82
Extremely
Oversold

Also see:
VTRS Market Cap History
VTRS Shares Outstanding History
VTRS YTD Return

Quotes delayed 20 minutes

Email EnvelopeFree VTRS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Confluent Breaks Above 200-Day Moving Average - Bullish for CFLT
56 minutes ago


OLLI Makes Bullish Cross Above Critical Moving Average
1 hour, 16 minutes ago


Bullish Two Hundred Day Moving Average Cross - AY
1 hour, 17 minutes ago


Calamos Convertible and High Income Fund (CHY) Shares Cross Above 200 DMA
1 hour, 22 minutes ago


SYBT Crosses Above Key Moving Average Level
1 hour, 30 minutes ago


Apollo Commercial Real Estate Finance (ARI) Shares Cross Above 200 DMA
1 hour, 33 minutes ago


BlackRock Utility and Infrastructure Trust Breaks Above 200-Day Moving Average - Bullish for BUI
1 hour, 35 minutes ago


Bullish Two Hundred Day Moving Average Cross - UVV
1 hour, 38 minutes ago


ESE Makes Bullish Cross Above Critical Moving Average
1 hour, 38 minutes ago


Bullish Two Hundred Day Moving Average Cross - PHG
1 hour, 38 minutes ago


Haemonetics (HAE) Shares Cross Above 200 DMA
1 hour, 38 minutes ago


Bullish Two Hundred Day Moving Average Cross - SGY.CA
1 hour, 38 minutes ago


Cineplex Breaks Above 200-Day Moving Average - Bullish for CGX.CA
1 hour, 38 minutes ago


Bullish Two Hundred Day Moving Average Cross - PHVS
4 hours, 26 minutes ago


Bullish Two Hundred Day Moving Average Cross - BLTE
4 hours, 27 minutes ago


More Technical Analysis News

VTRS Technical AnalysisVTRS RSI
Viatris is a healthcare company. Co.'s portfolio comprises of approved molecules across a range of therapeutic areas, including brands, generic, complex generic and biosimilars. From cardiovascular health to oncology, Co. provides treatment options across therapeutic areas covering a variety of non-communicable and infectious diseases. Co. also provides support services such as diagnostic clinics, educational seminars and digital tools. Co. provides a range of treatment options across all its therapeutic areas, with several categories containing several products in a range of dosage forms, formulations and delivery systems that allow physicians to tailor care for optimal treatment.

When researching a stock like Viatris, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from VTRS Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for VTRS stock — the real life supply and demand for the stock over time — and examines that data in different ways.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
VTRS DMAVTRS MACD
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Viatris (VTRS) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

WAT Technical Analysis
WST Technical Analysis
ZBH Technical Analysis
ZTS Technical Analysis
A Technical Analysis
ABBV Technical Analysis
ABT Technical Analysis
ALGN Technical Analysis
AMGN Technical Analysis
BAX Technical Analysis
More Healthcare companies »

 

Viatris Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2024, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.